BIOSCI 101 Lecture 6

Context & Big Picture

  • Yesterday’s citric acid (Krebs/TCA) cycle generated large amounts of NADH\text{NADH} and FADH2\text{FADH}_2.
  • Today: follow their electrons through the Electron-Transport Chain (ETC) to O2\text{O}_2 and ultimately to water, generating a proton motive force (PMF) used next week for ATP synthesis (oxidative phosphorylation).
  • Overall reaction (per 2 e⁻):
    1/2 O<em>2+2e−+2H+  ⟶  H</em>2O\text{1/2 O}<em>2 + 2 e^- + 2 H^+ \;\longrightarrow\; \text{H}</em>2\text{O}
    (Full physiological reaction uses 4 e⁻ and 4 H⁺ → 2 H₂O.)

Mitochondria: Location, Number & Ultrastructure

  • Quantity correlates with ATP demand.
    • Skeletal muscle: moderate density.
    • Cardiac muscle: ∼32−35%\sim 32{-}35\% of cell volume is mitochondria.
    • Insect flight muscle (e.g., honeybee) – extreme packing; wings beat 200−250  Hz200{-}250\;\text{Hz} (mosquito 350−700  Hz350{-}700\;\text{Hz}).
  • Placement: clustered near actin–myosin contractile machinery because ATP diffuses poorly.
  • Dynamics: mitochondria fuse into long tubules when active; undergo fission at rest. Fusion may enhance respiratory efficiency; mechanism still unclear.
  • Cristae geometry:
    • ATP-synthase dimers line the cristae ridges (V-shaped).
    • Respiratory complexes (I, III, IV) populate flat regions.
  • Electron micrographs highlight:
    • Dark matrix (loaded with TCA enzymes).
    • Membrane-embedded “black blobs” = mainly ATP synthase.
    • White clefts = inter-membrane space where protons accumulate.
    • Occasional inter-mitochondrial junctions (possible communication sites).

ETC – Overview & Flow of Electrons

NADH → Complex I ┐                 ┌→ Complex IV → O2
                   │                 │
FADH2→ Complex II ┘→ Q (CoQ) → Complex III → Cyt c ┘
  • Coupling concept: electron flow downhill in redox potential drives proton translocation uphill across the inner membrane (matrix → inter-membrane space).
  • PMF components:
    • ΔpH (chemical gradient).
    • ΔΨ (membrane potential, matrix negative).

Battery Analogy & Redox Potentials

  • Treat NADH/FADH₂ as batteries: their e⁻ sit at high free energy relative to O₂.
    • E<em>O</em>2/H<em>2O=+0.815  VE<em>{\text{O}</em>2/\text{H}<em>2\text{O}} = +0.815\;\text{V} (strong oxidant). • E</em>NAD+/NADH=−0.315  VE</em>{\text{NAD}^+/\text{NADH}} = -0.315\;\text{V}.
    ⇒ ΔE=1.14  V\Delta E = 1.14\;\text{V} (NADH).
    • ΔE  (FADH2)≈0.80  V\Delta E \;(\text{FADH}_2) \approx 0.80\;\text{V} → ≈28%\approx 28\% less “push” than NADH (cf. 9-V vs 6-V battery).

Complex I – NADH:Ubiquinone Oxidoreductase

  • L-shaped “gumboot”; 45 subunits (14 core). Bacterial structure solved 2013; eukaryotic form adds accessory units.
  • Evolutionary roots:
    • Peripheral arm ≈ ancient formate dehydrogenase.
    • Membrane arm ≈ ancestral Na⁺/K⁺ pumps.
  • Cofactors: FMN (from vitamin B₂) + chain of Fe–S centres.
  • Mechanism (per NADH = 2 e⁻):
    1. NADH → FMN → Fe–S relay.
    2. Electrons reduce ubiquinone (Q) bound in heel pocket → ubiquinol (QH₂).
    3. Electron movement alters electrostatics, driving piston-like shifts that pump 4 H⁺ (matrix → IMS).

Quinone Chemistry (Coenzyme Q)

  • Core benzoquinone ring + isoprenoid tail (lipid-soluble).
    • Humans: Q₁₀ (10 isoprenoid units).
    • Rats: Q₉ predominant.
  • Redox states:
    • Oxidised quinone (Q) – 2 keto groups.
    • 1-electron semi-quinone (Q•⁻) – reactive, pro-oxidant.
    • 2-electron reduced quinol (QH₂) – antioxidant; “legless” in lecturer’s beer analogy.
  • Widely used as dietary supplement/skin creams (antioxidant, cardiac benefits).

Complex II – Succinate Dehydrogenase

  • Dual role: TCA step & ETC entry point.
    • Succinate + FAD → Fumarate + FADH₂.
  • Structure: 4 core subunits; embedded FAD; 3 Fe–S centres + heme b.
  • Passes electrons to Q → QH₂ without pumping protons (insufficient driving force).

Complex III – Cytochrome bc₁ & the Q Cycle

  • Not a physical pump yet moves 4 H⁺ per 2 e⁻ via chemistry.
  • Key prosthetic groups: 2 heme b, Rieske Fe–S centre, heme c₁.
  • Q Cycle (simplified, per 2 e⁻):
    1. First QH₂ docks at Qo site → releases 2 H⁺ to IMS.
      • e⁻(1) → Rieske → heme c₁ → cytochrome c.
      • e⁻(2) → heme bL → heme bH → Qi site (stored on bound Q → Q•⁻).
    2. Second QH₂ repeats step 1 → total 4 H⁺ released.
      • Stored semiquinone at Qi picks up e⁻ + 2 H⁺ (matrix) → regenerates QH₂.
      ⇒ Net: 4 H⁺ translocated, 2 cyt c reduced, 1 QH₂ consumed (because one is regenerated).

Cytochrome c

  • Small soluble heme protein (≈12 kDa) in inter-membrane space; tethered by cardiolipin.
    • Each molecule carries 1 e⁻ from Complex III → IV.
  • Color change on redox (basis of spectroscopic assays).

Complex IV – Cytochrome c Oxidase

  • Metal centres: CuA, heme a, heme a₃–CuB binuclear centre.
  • Reaction (per O₂): O<em>2+4e−+4H+</em>matrix→2H2O\text{O}<em>2 + 4 e^- + 4 H^+</em>{\text{matrix}} → 2 \text{H}_2\text{O}.
  • Conformational cycling during O₂ reduction pumps 2 H⁺ per 2 e⁻ (textbook simplification; full 4 H⁺ per O₂).
  • O₂ binding transiently splits; improper turnover yields ROS, hence tight control.

Net Proton Budget & ATP Yield

  • Per NADH (via I–III–IV): 4+4+2=10  H+4 + 4 + 2 = 10\;H^+ → later ≈ 104≈2.5 ATP\frac{10}{4} \approx 2.5 \text{ ATP}.
  • Per FADH₂ (via II–III–IV): 0+4+2=6  H+0 + 4 + 2 = 6\;H^+ → ≈ 1.5 ATP1.5 \text{ ATP}.
  • Variations reflect the lower redox span of FADH₂.

Super-complexes (Respirosomes)

  • Complexes I+III+IV can assemble into super-complex; larger mega-complexes hinted.
  • Advantages:
    • Substrate channeling (bucket-brigade efficiency).
    • Reduced ROS leakage.
    • Arrangement adapts to metabolic state:
    – Glucose-fed (NADH-rich) → more I-containing super-complexes.
    – Fasting/fat oxidation (FADH₂-rich) → fewer.

Inhibitors & Poisons

TargetRepresentative inhibitorsNotes/Consequences
Complex IAmytal (barbiturate, “truth serum”); rotenone (plant insecticide); halogenated anesthetics (isoflurane)Rotenone linked to Parkinson-like symptoms; fish extremely sensitive
Complex IIMalonate (competitive); TTFALess clinically relevant
Complex IIIAntimycin A; myxothiazolBlocks Qi or Qo site → ROS generation
Complex IVCyanide (\text{CN}⁻); CO; NO; H₂SBind heme/Cu_B; cyanide reversible with pyruvate injection; NO acts as endogenous regulator during hypoxia
ATP-synthase (next lecture)Oligomycin—

Spectroscopic Monitoring of ETC

  • Metal centres shift absorption peaks upon redox.
    • Classic setup: white light → prism → sample cuvette → spectral chart.
    • Peaks disappear/appear when chain inhibited (e.g., rotenone → upstream oxidation; antimycin → upstream reduction; cyanide or anoxia → global reduction).
  • Clinical/Research use: Near-infrared spectroscopy through infant fontanelle to monitor cerebral mitochondrial status during surgery.

Ethical / Practical Implications

  • Agricultural use of rotenone & H₂S hazards illustrate ecological and health risks of ETC poisons.
  • Understanding ETC dynamics vital for anesthetic safety, hypoxia tolerance, metabolic diseases, and antioxidant therapy (CoQ10 supplementation).

Numerical Highlights & Equations

  • Heart mitochondrial volume: 32–35%32\text{–}35\% of cardiomyocyte.
  • Bee wing beat: 200–250  s−1200\text{–}250\;\text{s}^{-1}; mosquito up to 700  s−1700\;\text{s}^{-1}.
  • Proton pumping summary (per 2 e⁻):
    • Complex I: 4  H+4\;H^+.
    • Complex III (Q cycle): 4  H+4\;H^+.
    • Complex IV: 2  H+2\;H^+ (textbook).
    ⇒ NADH total =10  H+=10\;H^+; FADH₂ total =6  H+=6\;H^+.
  • Redox potentials:
    E<em>NADH→O</em>2=1.14  V,E<em>FADH</em>2→O2≈0.80  VE<em>{\text{NADH} \to \text{O}</em>2} = 1.14\;\text{V},\quad E<em>{\text{FADH}</em>2 \to \text{O}_2} \approx 0.80\;\text{V}.

Looking Ahead

  • Tuesday’s lecture: how accumulated protons spin the ATP synthase turbine to phosphorylate ADP → ATP (chemiosmotic coupling).
  • Lecturer preparing alternative model to classical PMF view – stay tuned.